Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma.
Shuo WangXiao-Long WangZhi-Zhong WuQi-Chao YangHong-Gang XiongYao XiaoHao LiZhi-Jun SunPublished in: Oral diseases (2020)
Ribonucleotide reductase M2 may be a novel target in the diagnosis, prognosis, and therapy of OSCC.